cefuroxime has been researched along with Urethral Diseases in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Urethral Diseases: Pathological processes involving the URETHRA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stolz, E | 1 |
| Ong, L | 1 |
| van Joost, T | 1 |
| Michel, MF | 1 |
1 trial available for cefuroxime and Urethral Diseases
| Article | Year |
|---|---|
Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g.
Topics: beta-Lactamases; Cefotaxime; Cefuroxime; Cephalosporins; Female; Gonorrhea; Humans; Male; Neisseria | 1984 |